Get started
Author

Yali Cao

Observed names: Y. Cao, Yali CAO
ORCID: 0009-0008-6465-2880
Observed ORCID: 0009-0008-6465-2880
OpenAlex ID: A5100435447
Factors influencing pathological complete response to neoadjuvant chemotherapy in resectable breast cancer: A retrospective study
2025 · Jian Kang, Huifen Xiong, et al. · Oncology Letters · 9
PDF
A New Predictive Scoring System Based on Clinical Data and Computed Tomography Features for Diagnosing EGFR-mutated Lung Adenocarcinoma
2018 · Y. Cao, H. Xu · Current Oncology · 8
PDF
The prevalence of non-sentinel lymph node metastasis among breast cancer patients with sentinel lymph node involvement and its impact on clinical decision-making: a single-centred retrospective study
2024 · Jingxian Ding, Xiaoliu Jiang, et al. · Oncology Reviews · 5
PDF
The prevalence and genetic disorders spectrum of thalassemia among breast cancer patients in Jiangxi province, China
2022 · Jingxian Ding, Zhaohui Huang, et al. · Frontiers in Genetics · 5
PDF
1045P Safety and preliminary clinical activity of JNJ-78306358 (JNJ-358), an HLA-G and CD3 bispecific antibody, for the treatment of advanced stage solid tumor
2023 · R. Geva, M. Vieito Villar, et al. · Annals of Oncology · 3
PDF
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China
2023 · Shaohua Zhang, Jianbin Li, et al. · JMIR Public Health and Surveillance · 1
PDF
ASO Visual Abstract: Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer—Development and Validation of a Clinical-Inflammatory Nomogram
2026 · Xiaoliu Jiang, Zhaohui Huang, et al. · Annals of Surgical Oncology
PDF
Correlation of EPO gene polymorphism with gestational diabetes mellitus
2021 · Hui ZHANG, Yanyan JING, et al. · Panminerva Medica
Works count: 8
Citation count: 31
H-index: 4
I10-index:
Year
Topic
Type